Rezultati pretraživanja
  1. 13. ruj 2019.

    If you're attending don't miss Therapeutics™ CEO Pieter Rottiers' overview of the innovative ® platform and its applications on October 1. Read more: , follow us on Linkedin or Twitter

  2. 3. tra 2018.
  3. 23. kol 2019.
  4. 8. sij 2018.

    REMINDER: Intrexon will host two presentations this week. A live webcast of the presentations will be available on the Investors section of Intrexon's website at . Please share.

  5. 30. svi 2018.

    Nice update in from Actobio Therapeutics ! using former technology ...

  6. 29. lis 2018.

    A new milestone in the treatment of ActoBio Therapeutics™ Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes. full press release:

  7. 26. ožu 2019.

    ActoBio Therapeutics' CEO Pieter Rottiers will participate in a panel discussion entitled “Evaluation of Combination Therapies to Address Unmet Clinical Needs” on THU March 28th at 14:30 PM.

  8. 2. sij 2019.

    Breaking: intrexon announces 4 presentations at upcoming investor conferences. Discover more:

  9. 9. sij 2018.

    ICYMI: Replay of the Biotech Showcase 2018 Conference presentation by Pieter Rottiers, PhD, ActoBio's CEO, is now available on demand on the Investors section of Intrexon's website at .

  10. 19. srp 2019.
  11. 6. tra 2013.
  12. 1. lis 2019.

    At ? Don't miss Therapeutics™ CEO Pieter Rottiers' presentation at 4PM today about the innovative ActoBiotics® platform. More: or follow on Twitter or LinkedIn.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.